Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials
Open Access
- 1 January 2010
- journal article
- Published by Hindawi Limited in Stem Cells International
- Vol. 2010, 1-14
- https://doi.org/10.4061/2010/519028
Abstract
Mesenchymal progenitor cells (MPCs) are nonhematopoietic multipotent cells capable of differentiating into mesenchymal and nonmesenchymal lineages. While they can be isolated from various tissues, MPCs isolated from the bone marrow are best characterized. These cells represent a subset of bone marrow stromal cells (BMSCs) which, in addition to their differentiation potential, are critical in supporting proliferation and differentiation of hematopoietic cells. They are of clinical interest because they can be easily isolated from bone marrow aspirates and expanded in vitro with minimal donor site morbidity. The BMSCs are also capable of altering disease pathophysiology by secreting modulating factors in a paracrine manner. Thus, engineering such cells to maximize therapeutic potential has been the focus of cell/gene therapy to date. Here, we discuss the path towards the development of clinical trials utilizing BMSCs for orthopaedic applications. Specifically, we will review the use of BMSCs in repairing critical-sized defects, fracture nonunions, cartilage and tendon injuries, as well as in metabolic bone diseases and osteonecrosis. A review of www.ClinicalTrials.gov of the United States National Institute of Health was performed, and ongoing clinical trials will be discussed in addition to the sentinel preclinical studies that paved the way for human investigations.Funding Information
- National Institutes of Health (CA106569, AR50142, AR054381, 30901530, 30800658, 2008BB5396, 2009BB5060)
This publication has 133 references indexed in Scilit:
- Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surfaceJournal of Tissue Engineering and Regenerative Medicine, 2009
- Enumeration of the colony-forming units–fibroblast from mouse and human bone marrow in normal and pathological conditionsStem Cell Research, 2009
- Capture of Authentic Embryonic Stem Cells from Rat BlastocystsCell, 2008
- Creation of New Bone by the Percutaneous Injection of Human Bone Marrow Stromal Cell and HA/TCP SuspensionsTissue Engineering, Part A, 2008
- Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphateBiomaterials, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructsJournal of Orthopaedic Research, 2004
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998